Women's Perception of Respectful Maternity Care, Birth Experiences and Perception of Traumatic Birth

NCT ID: NCT06691854

Last Updated: 2025-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

124 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-01

Study Completion Date

2025-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effect of the ıntrapartum care model given in line with the world health organization (WHO) recommendations on women's perception of respectful maternity care, birth experiences and perception of traumatic birth

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research is a randomized controlled trial. The research will conducted with 124 primiparous pregnant women (intervention group n=62, control group n=62) who were hospitalized in the delivery unit of Aksaray Training and Research Hospital between September 2023 and January 2024. The pregnant women in the intervention group will given the intrapartum care model in line with WHO recommendations after cervical dilation reached 5 cm. The control group will received only the standard intrapartum care in the hospital. Data will be collected using the personal information form, birth follow-up form, respectful maternal care scale, birth experience scale, and traumatic birth perception scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maternity Birth, First Traumatic Birth Intrapartum Fetal Distress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo group

Pregnant women who apply to the hospital for delivery, have a cervical dilatation of 5 cm or more, agree to participate in the study and are assigned to the control group;

* A personal information form will be applied at the first clinic admission.
* Pregnant women assigned to the control group will receive routine intrapartum care provided at the hospital.
* The labor process of the pregnant woman will be recorded on the birth experience monitoring form.
* The mother and baby will receive routine postpartum care provided at the hospital.
* After delivery, the Respectful maternity care scale, Birth experience scale, Traumatic birth perception scale will be applied.

Group Type NO_INTERVENTION

No interventions assigned to this group

The group that applied the Intrapartum Care Model

Pregnant women who apply to the hospital for delivery, have cervical dilatation of 5 cm and above, agree to participate in the study and are assigned to the intervention group;

* A Personal Information form will be applied at the first clinic admission.
* All primiparous pregnant women assigned to the intervention group will be applied the intrapartum care model by the research midwife during the labor process and after birth in line with the WHO positive birth recommendations (Table 1).
* The labor process of the pregnant woman will be recorded on the birth experience follow-up form.
* After birth, the Respectful maternity care scale, Birth experience scale, Traumatic birth perception scale will be applied.

Group Type EXPERIMENTAL

The group that applied the Intrapartum Care Model

Intervention Type OTHER

Pregnant women who apply to the hospital for delivery, have cervical dilatation of 5 cm and above, agree to participate in the study and are assigned to the intervention group;

A Personal Information form will be applied at the first clinic admission. All primiparous pregnant women assigned to the intervention group will be applied the intrapartum care model by the research midwife during the labor process and after birth in line with the WHO positive birth recommendations.

The labor process of the pregnant woman will be recorded on the birth experience follow-up form.

After birth, the Respectful maternity care scale, Birth experience scale, Traumatic birth perception scale will be applied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The group that applied the Intrapartum Care Model

Pregnant women who apply to the hospital for delivery, have cervical dilatation of 5 cm and above, agree to participate in the study and are assigned to the intervention group;

A Personal Information form will be applied at the first clinic admission. All primiparous pregnant women assigned to the intervention group will be applied the intrapartum care model by the research midwife during the labor process and after birth in line with the WHO positive birth recommendations.

The labor process of the pregnant woman will be recorded on the birth experience follow-up form.

After birth, the Respectful maternity care scale, Birth experience scale, Traumatic birth perception scale will be applied.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those who are 18 years of age or older,
* Those who are in term pregnancy (38-41 weeks),
* Those who are primiparous,
* Those who have a single, healthy, vertex positioned fetus,
* Those who have cervical dilatation of 5 cm or more,
* Those who can speak and understand Turkish,
* Those who voluntarily agree to participate in the research.

Exclusion Criteria

* Those with chronic diseases (hypertension, diabetes, etc.),
* Those with a diagnosed mental illness (depression, anxiety or other psychotic disorder, etc.),
* Those with maternal and fetal complications (oligohydramnios and polyhydramnios, placenta previa, preeclampsia, premature membrane rupture, presentation anomalies, intrauterine growth retardation, fetal anomalies, intrauterine death, macrosomic baby, cord prolapse, etc.),
* Those with any complications that prevent vaginal birth (cephalopelvic disproportion, etc.),
* Elective cesarean section,
* Those who became pregnant with assisted reproductive techniques,
* Those who received childbirth preparation training.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Selcuk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seyhan Çankaya

Assoc. Prof. Seyhan Çankaya

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Seyhan Çankaya, PhD

Role: PRINCIPAL_INVESTIGATOR

Selcuk University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seyhan Çankaya

Konya, Konya, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/982

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.